ESR2 and breast cancer: Other experimental studies have demonstrated that ERβ overexpression can also increase the level of integrin αI [94], growth-inhibitory p21/WAF and epithelial cell marker cytokeratin 8 [66], consequently modulating adhesion and migration of breast cancer cells.